Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James Michael Wardleworth is active.

Publication


Featured researches published by James Michael Wardleworth.


Cancer Investigation | 2008

Farnesyl transferase inhibitors

James Michael Wardleworth; Francis Thomas Boyle; Zbigniew Stanley Matusiak

Ras proteins belong to the small guanine triphosphatebinding protein (G protein) superfamily that is widely distributed in mammalian cells (1–3). The G protein superfamily consists of more than 100 members that are structurally classified into at least five families, including the Ras, Rho, Rab, Sarl/Arf, and Ran families. They all have consensus amino acid sequences for specific binding with guanosine diphosphate (GDP) and guanosine triphosphate (GTP), for GTPase activity (which hydrolyzes bound GTP to GDP and Pi) and for downstream effectors. G proteins regulate a wide variety of cellular functions, including gene expression in normal cell growth and differentiation (Ras), cytoskeletal reorganization and gene expression (Rho), vesicle trafficking (Rab and Sarl/Arf), nucleocytoplasmic transport (Ran), and microtubule organization (Ran). They are structurally similar and are physiologically regulated by many of the same signals. Multiple upstream regulators and downstream effectors have been identified, and their modes of activation and crosstalk have been extensively studied (4, 5).


Archive | 1996

4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors

David Huw Davies; Francis Thomas Boyle; James Michael Wardleworth; Peter Wedderburn Kenny; Peter Beverley Scholes; Zbigniew Stanely Matusiak


Archive | 1978

Guanidine derivatives of imidazoles and thiazoles

David J. Gilman; James Michael Wardleworth; Tobias O. Yellin


Archive | 1985

Antifungal azole compounds

Richard William Bayles; Francis Thomas Boyle; Michael Barry Gravestock; James Michael Wardleworth


Archive | 1998

Imidazolyl compounds as inhibitors of farnesyl-protein tranferase

Francis Thomas Boyle; Gareth M. Davies; James Michael Wardleworth; Jean-Claude Arnould


Archive | 1991

Optically active triazole derivatives and compositions

Kimihiro Murakami; Hidenori Mochizuki; Francis Thomas Boyle; James Michael Wardleworth


Archive | 2002

Anti-tumor compounds

Robert George Andrew; Andrew J. Barker; Francis Thomas Boyle; James Michael Wardleworth


Archive | 1991

Anti-tumour compounds.

Robert George Andrew; Andrew J. Barker; Francis Thomas Boyle; James Michael Wardleworth


Archive | 1997

3-Mercaptopyrrolidines as farnesyl protein transferase inhibitors

Francis Thomas Boyle; James Michael Wardleworth


Archive | 1988

Heterocyclic olefinic compounds and their use as aromatase inhibitors

Francis Thomas Boyle; James Michael Wardleworth; Zbigniew Stanley Matusiak

Collaboration


Dive into the James Michael Wardleworth's collaboration.

Top Co-Authors

Avatar

Francis Thomas Boyle

Imperial Chemical Industries

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kimihiro Murakami

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Andrew J. Barker

Imperial Chemical Industries

View shared research outputs
Top Co-Authors

Avatar

David J. Gilman

Imperial Chemical Industries

View shared research outputs
Top Co-Authors

Avatar

Robert George Andrew

Imperial Chemical Industries

View shared research outputs
Top Co-Authors

Avatar

Derrick Fleet Jones

Imperial Chemical Industries

View shared research outputs
Researchain Logo
Decentralizing Knowledge